Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery ; volume:20 ; number:1 ; day:24 ; month:1 ; year:2022 ; pages:1-15 ; date:12.2022
Journal of nanobiotechnology ; 20, Heft 1 (24.1.2022), 1-15, 12.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-022-01257-4
- URN
-
urn:nbn:de:101:1-2022050420274664109845
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Lingling
- Yang, Jianmiao
- Wang, Tiantian
- Gao, Jianqing
- Xu, Donghang
- SpringerLink (Online service)
Ähnliche Objekte (12)
6 Small-Molecule Motion
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small-molecule modifiers for DNA nanostructures
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
One-photon red light-triggered disassembly of small-molecule nanoparticles for drug delivery
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Energy losses in small-molecule organic photovoltaics
Small-Molecule Inhibitors of p53-MDM2 interactions
6 Small-Molecule Motion
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small-molecule modifiers for DNA nanostructures
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
One-photon red light-triggered disassembly of small-molecule nanoparticles for drug delivery
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Energy losses in small-molecule organic photovoltaics
Small-Molecule Inhibitors of p53-MDM2 interactions
6 Small-Molecule Motion
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small-molecule modifiers for DNA nanostructures
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
One-photon red light-triggered disassembly of small-molecule nanoparticles for drug delivery
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Energy losses in small-molecule organic photovoltaics